Works about DOXORUBICIN
Results: 5000
Impact of corvitin and alpha-ketoglutarate on heart morphology, expression and activity of matrix metalloproteinases 2/9 in the heart of rats with doxorubicin-induced cardiomyopathy.
- Published in:
- Regulatory Mechanisms in Biosystems, 2019, v. 10, n. 4, p. 372, doi. 10.15421/021956
- By:
- Publication type:
- Article
Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells.
- Published in:
- BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04829-7
- By:
- Publication type:
- Article
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 263, doi. 10.3390/pharmaceutics17020263
- By:
- Publication type:
- Article
Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 246, doi. 10.3390/pharmaceutics17020246
- By:
- Publication type:
- Article
Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 248, doi. 10.3390/ph18020248
- By:
- Publication type:
- Article
SA4503 Mitigates Adriamycin-Induced Nephropathy via Sigma-1 Receptor in Animal and Cell-Based Models.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 172, doi. 10.3390/ph18020172
- By:
- Publication type:
- Article
Comparison of the Efficacy of 15- and 19-Week Chemotherapy Protocols Based on Vincristine, L-Asparaginase, Doxorubicin, and Prednisolone for Dogs with Multicentric Lymphoma.
- Published in:
- Animals (2076-2615), 2025, v. 15, n. 4, p. 522, doi. 10.3390/ani15040522
- By:
- Publication type:
- Article
Facile One-Pot Preparation of Self-Assembled Hyaluronate/Doxorubicin Nanoaggregates for Cancer Therapy.
- Published in:
- Biomimetics (2313-7673), 2025, v. 10, n. 2, p. 91, doi. 10.3390/biomimetics10020091
- By:
- Publication type:
- Article
Ameliorative Effects of Thymoquinone against Chemotherapy-Induced Testicular Damage in Experimental Animals: A Systematic Review.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 4, p. 35, doi. 10.21315/mjms2024.31.4.3
- By:
- Publication type:
- Article
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting.
- Published in:
- Wiener Klinische Wochenschrift, 2010, v. 122, n. 21/22, p. 649, doi. 10.1007/s00508-010-1483-1
- By:
- Publication type:
- Article
Costs of toxicity during chemotherapy with CHOP, COP/CVP, and fludarabine.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 3, p. 166, doi. 10.1007/s10198-002-0112-y
- By:
- Publication type:
- Article
COMPERATIVE STUDY OF PRIMARY AND SECONDARY STRUCTURE OF DNA OF E. COLI OF HEALTHY AND CANCER-SICK PERSONS AND THEIR INFLUENCE ON THE DNA OF TUMOR CELL.
- Published in:
- Electronic Journal of Natural Sciences, 2012, v. 19, n. 2, p. 14
- By:
- Publication type:
- Article
THE CHANGE IN THE STRUCTURE OF TUMOR DNA UNDER THE COMBINED ACTION OF BACTERIAL CULTURE E. coli AND DOXORUBICIN A IN VIVO.
- Published in:
- Electronic Journal of Natural Sciences, 2004, v. 3, n. 2, p. 36
- By:
- Publication type:
- Article
MODIFYING EFFECT OF VITAMIN E ON ADRIAMYCIN AND CYCLOPHOSPHAMIDE INDUCED GENOTOXICITY AND ANTIOXIDANT STATUS IN RATS.
- Published in:
- Veterinarija ir Zootechnika, 2013, v. 65, n. 87, p. 72
- By:
- Publication type:
- Article
In Vivo Anti-Tumor Activity of a New Doxorubiein Conjugate via α-Linolenic Acid.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 8, p. 1577, doi. 10.1271/bbb.120256
- By:
- Publication type:
- Article
BLADDER CANCER.
- Published in:
- Current Medical Literature: Urology, 2005, v. 11, n. 4, p. 95
- Publication type:
- Article
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 4, p. 542, doi. 10.1111/vco.13004
- By:
- Publication type:
- Article
Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 278, doi. 10.1111/vco.12975
- By:
- Publication type:
- Article
Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 54, doi. 10.1111/vco.12860
- By:
- Publication type:
- Article
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 2, p. 362, doi. 10.1111/vco.12680
- By:
- Publication type:
- Article
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 664, doi. 10.1111/vco.12590
- By:
- Publication type:
- Article
Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 147, doi. 10.1111/vco.12455
- By:
- Publication type:
- Article
Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 622, doi. 10.1111/vco.12430
- By:
- Publication type:
- Article
Response rate to a single dose of vinblastine administered to dogs with treatment‐naive multicentric lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 636, doi. 10.1111/vco.12433
- By:
- Publication type:
- Article
Pre‐clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 544, doi. 10.1111/vco.12413
- By:
- Publication type:
- Article
Engineering controls in veterinary oncology: A survey of 148 ACVIM board‐certified oncologists and environmental surveillance in 20 specialty hospitals.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 385, doi. 10.1111/vco.12390
- By:
- Publication type:
- Article
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 194, doi. 10.1111/vco.12335
- By:
- Publication type:
- Article
Oral melphalan for the treatment of relapsed canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E123, doi. 10.1111/vco.12356
- By:
- Publication type:
- Article
Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co( II) and Zn( II) compounds.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1537, doi. 10.1111/vco.12298
- By:
- Publication type:
- Article
Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 1087, doi. 10.1111/vco.12250
- By:
- Publication type:
- Article
The effects of sulforaphane on canine osteosarcoma proliferation and invasion.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 718, doi. 10.1111/vco.12212
- By:
- Publication type:
- Article
Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 754, doi. 10.1111/vco.12215
- By:
- Publication type:
- Article
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 919, doi. 10.1111/vco.12232
- By:
- Publication type:
- Article
Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 421, doi. 10.1111/vco.12179
- By:
- Publication type:
- Article
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 493, doi. 10.1111/vco.12193
- By:
- Publication type:
- Article
Assessment of cardiac troponin I ( cTnI) and tissue velocity imaging ( TVI) in 14 dogs with malignant lymphoma undergoing chemotherapy treatment with doxorubicin.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 55, doi. 10.1111/vco.12135
- By:
- Publication type:
- Article
Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 25, doi. 10.1111/vco.12139
- By:
- Publication type:
- Article
Nucleated erythrocytes in blood smears of dogs undergoing chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 215, doi. 10.1111/vco.12156
- By:
- Publication type:
- Article
Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs<sup>†</sup>.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 4, p. e171, doi. 10.1111/vco.12131
- By:
- Publication type:
- Article
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, p. 147, doi. 10.1111/vco.12163
- By:
- Publication type:
- Article
Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, p. 136, doi. 10.1111/vco.12158
- By:
- Publication type:
- Article
Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 1, p. 81, doi. 10.1111/vco.12069
- By:
- Publication type:
- Article
The effects of baicalein on canine osteosarcoma cell proliferation and death.
- Published in:
- Veterinary & Comparative Oncology, 2014, v. 12, n. 4, p. 299, doi. 10.1111/vco.12013
- By:
- Publication type:
- Article
Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).
- Published in:
- Veterinary & Comparative Oncology, 2014, v. 12, n. 4, p. 266, doi. 10.1111/vco.12001
- By:
- Publication type:
- Article
Development of a limited-sampling model for prediction of doxorubicin exposure in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2014, v. 12, n. 2, p. 114, doi. 10.1111/j.1476-5829.2012.00340.x
- By:
- Publication type:
- Article
Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 1, p. 44, doi. 10.1111/j.1476-5829.2011.00274.x
- By:
- Publication type:
- Article
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 1, p. 55, doi. 10.1111/j.1476-5829.2010.00235.x
- By:
- Publication type:
- Article
Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient W. M. FitzPatrick et al.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 4, p. 273, doi. 10.1111/j.1476-5829.2010.00225.x
- By:
- Publication type:
- Article
Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 3, p. 188, doi. 10.1111/j.1476-5829.2010.00215.x
- By:
- Publication type:
- Article
Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 3, p. 221, doi. 10.1111/j.1476-5829.2010.00221.x
- By:
- Publication type:
- Article